Back to Search
Start Over
Efficacy and Safety of Intratumoral Injection of Recombinant Human Adenovirus Type 5 Combined With Tislelizumab and Lenvatinib in the Treatment of Advanced Hepatocellular Carcinoma: a Single-center, Prospective, Single-arm Study.
- Source :
- Cancer Gene Therapy Week; 2024, p32-32, 1p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 15436837
- Database :
- Complementary Index
- Journal :
- Cancer Gene Therapy Week
- Publication Type :
- Periodical
- Accession number :
- 175614887